{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:38:25Z","timestamp":1790797105758,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2013,4,12]],"date-time":"2013-04-12T00:00:00Z","timestamp":1365724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11010-013-1579-9","type":"journal-article","created":{"date-parts":[[2013,4,11]],"date-time":"2013-04-11T09:09:24Z","timestamp":1365671364000},"page":"1-7","source":"Crossref","is-referenced-by-count":60,"title":["The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells"],"prefix":"10.1007","volume":"378","author":[{"given":"Yan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huidi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangmei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,12]]},"reference":[{"key":"1579_CR1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3322\/canjclin.56.2.106","volume":"56","author":"A Jemal","year":"2006","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56:106\u2013130","journal-title":"CA Cancer J Clin"},{"key":"1579_CR2","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351:2519\u20132529","journal-title":"N Engl J Med"},{"key":"1579_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","volume":"55","author":"J Hunn","year":"2012","unstructured":"Hunn J, Rodriguez GC (2012) Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 55:3\u201323","journal-title":"Clin Obstet Gynecol"},{"key":"1579_CR4","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1158\/0008-5472.CAN-04-0552","volume":"64","author":"A Bardin","year":"2004","unstructured":"Bardin A, Hoffmann P, Boulle N, Katsaros D, Vignon F, Pujol P, Lazennec G (2004) Involvement of estrogen receptor beta in ovarian carcinogenesis. Cancer Res 64:5861\u20135869","journal-title":"Cancer Res"},{"key":"1579_CR5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/gyno.1996.0181","volume":"62","author":"M Markman","year":"1996","unstructured":"Markman M, Iseminger KA, Hatch KD, Creasman WT, Barnes W, Dubeshter B (1996) Tamoxifen in platinum-refractory ovarian cancer: a gynecologic oncology group ancillary report. Gynecol Oncol 62:4\u20136","journal-title":"Gynecol Oncol"},{"key":"1579_CR6","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1071-5576(01)00093-4","volume":"8","author":"LJ Havrilesky","year":"2001","unstructured":"Havrilesky LJ, McMahon CP, Lobenhofer EK, Whitaker R, Marks JR, Berchuck A (2001) Relationship between expression of coactivators and corepressors of hormone receptors and resistance of ovarian cancers to growth regulation by steroid hormones. J Soc Gynecol Investig 8:104\u2013113","journal-title":"J Soc Gynecol Investig"},{"key":"1579_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12020-010-9363-z","volume":"38","author":"D Wang","year":"2010","unstructured":"Wang D, Hu L, Zhang G, Zhang L, Chen C (2010) G protein-coupled receptor 30 in tumor development. Endocrine 38:29\u201337","journal-title":"Endocrine"},{"key":"1579_CR8","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrendo.2011.122","volume":"7","author":"ER Prossnitz","year":"2011","unstructured":"Prossnitz ER, Barton M (2011) The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 7:715\u2013726","journal-title":"Nat Rev Endocrinol"},{"key":"1579_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbrc.2012.03.004","volume":"420","author":"SQ Ruan","year":"2012","unstructured":"Ruan SQ, Wang ZH, Wang SW, Fu ZX, Xu KL, Li DB, Zhang SZ (2012) Heregulin-\u03b21-induced GPR30 upregulation promotes the migration and invasion potential of SkBr3 breast cancer cells via ErbB2\/ErbB3-MAPK\/ERK pathway. Biochem Biophys Res Commun 420:385\u2013390","journal-title":"Biochem Biophys Res Commun"},{"key":"1579_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bbrc.2012.02.161","volume":"420","author":"GQ Du","year":"2012","unstructured":"Du GQ, Zhou L, Chen XY, Wan XP, He YY (2012) The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells. Biochem Biophys Res Commun 420:343\u2013349","journal-title":"Biochem Biophys Res Commun"},{"key":"1579_CR11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ygyno.2009.05.015","volume":"114","author":"HO Smith","year":"2009","unstructured":"Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER (2009) GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 114:465\u2013471","journal-title":"Gynecol Oncol"},{"key":"1579_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1757-2215-5-9","volume":"5","author":"Z Kolkova","year":"2012","unstructured":"Kolkova Z, Cassl\u00e9n V, Henic E, Ahmadi S, Ehinger A, Jirstr\u00f6m K, Cassl\u00e9n B (2012) The G protein-coupled estrogen receptor 1 (GPER\/GPR30) does not predict survival in patients with ovarian cancer. J Ovarian Res 5:9","journal-title":"J Ovarian Res"},{"key":"1579_CR13","first-page":"524","volume":"62","author":"HD Liu","year":"2010","unstructured":"Liu HD, Yan Y, Cao XF, Tan PZ, Wen HX, Lv CM, Li XM, Liu GY (2010) The expression of a novel estrogen receptor, GPR30, in epithelial ovarian carcinoma and its correlation with MMP-9. Sheng Li Xue Bao 62:524\u2013528","journal-title":"Sheng Li Xue Bao"},{"key":"1579_CR14","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(96)91015-6","volume":"347","author":"MB Sporn","year":"1996","unstructured":"Sporn MB (1996) The war on cancer. Lancet 347:1377\u20131381","journal-title":"Lancet"},{"key":"1579_CR15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1525-1438.2002.01152.x","volume":"12","author":"N Auersperg","year":"2002","unstructured":"Auersperg N, Ota T, Mitchell GW (2002) Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches. Int J Gynecol Cancer 12:691\u2013703","journal-title":"Int J Gynecol Cancer"},{"key":"1579_CR16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canlet.2004.04.024","volume":"220","author":"J Song","year":"2005","unstructured":"Song J, Fadiel A, Edusa V, Chen Z, So J, Sakamoto H, Fishman DA, Naftolin F (2005) Estradiol-induced ezrin overexpression in ovarian cancer: a new signaling domain for estrogen. Cancer Lett 220:57\u201365","journal-title":"Cancer Lett"},{"key":"1579_CR17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/emboj.2008.304","volume":"28","author":"DP Pandey","year":"2009","unstructured":"Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D (2009) Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF. EMBO J 28:523\u2013532","journal-title":"EMBO J"},{"key":"1579_CR18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00432-011-1133-7","volume":"138","author":"YY He","year":"2012","unstructured":"He YY, Du GQ, Cai B, Yan Q, Zhou L, Chen XY, Lu W, Yang YX, Wan XP (2012) Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2. J Cancer Res Clin Oncol 138:775\u2013783","journal-title":"J Cancer Res Clin Oncol"},{"key":"1579_CR19","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1158\/1078-0432.CCR-06-0860","volume":"12","author":"EJ Filardo","year":"2006","unstructured":"Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM, Sabo E (2006) Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 12:6359\u20136366","journal-title":"Clin Cancer Res"},{"key":"1579_CR20","doi-asserted-by":"crossref","first-page":"386.e1","DOI":"10.1016\/j.ajog.2007.01.004","volume":"196","author":"HO Smith","year":"2007","unstructured":"Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, Prossnitz ER (2007) GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 196:386.e1\u2013386.e11","journal-title":"Am J Obstet Gynecol"},{"key":"1579_CR21","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1158\/0008-5472.CAN-06-2909","volume":"67","author":"L Albanito","year":"2007","unstructured":"Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, And\u00f2 S, Maggiolini M (2007) G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67:1859\u20131866","journal-title":"Cancer Res"},{"key":"1579_CR22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2012.02.028","volume":"320","author":"MT Lau","year":"2012","unstructured":"Lau MT, So WK, Leung PC (2012) Integrin \u03b21 mediates epithelial growth factor-induced invasion in human ovarian cancer cells. Cancer Lett 320:198\u2013204","journal-title":"Cancer Lett"},{"key":"1579_CR23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/IGC.0b013e31819bcb75","volume":"19","author":"E Henic","year":"2009","unstructured":"Henic E, Noskova V, H\u00f8yer-Hansen G, Hansson S, Cassl\u00e9n B (2009) Estradiol attenuates EGF-induced rapid uPAR mobilization and cell migration via the G-protein-coupled receptor 30 in ovarian cancer cells. Int J Gynecol Cancer 19:214\u2013222","journal-title":"Int J Gynecol Cancer"},{"key":"1579_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2121-10-27","volume":"10","author":"TL Peng","year":"2009","unstructured":"Peng TL, Chen J, Mao W, Song X, Chen MH (2009) Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. BMC Cell Biol 10:27","journal-title":"BMC Cell Biol"},{"key":"1579_CR25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jnci\/94.15.1134","volume":"94","author":"S Huang","year":"2002","unstructured":"Huang S, Van Arsdall M, Tedjarati S, McCarty M, Wu W, Langley R, Fidler IJ (2002) Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 94:1134\u20131142","journal-title":"J Natl Cancer Inst"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-013-1579-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-013-1579-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-013-1579-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T22:15:13Z","timestamp":1559340913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-013-1579-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,12]]},"references-count":25,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1579"],"URL":"https:\/\/doi.org\/10.1007\/s11010-013-1579-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,12]]}}}